Literature DB >> 15199510

Epidemiology of venous thromboembolism.

C Kearon1.   

Abstract

The annual incidence of diagnosed venous thromboembolism (VTE) is 1 to 2 events per 1000 of the general population. VTE is very uncommon before age 20 years and, after 40 years of age, the incidence about doubles with each decade. Over half of episodes of VTE are deep vein thrombosis (DVT), and three quarters are first episodes. The incidence of VTE is similar in men and women and lower in Asians than it is in Caucasians or Africans. Hereditary risk factors include the factor V Leiden mutation; the G20210A prothrombin gene mutation; and deficiencies of protein C, protein S, and antithrombin. Hyperhomocysteinemia and elevated levels of factors I, VIII and XI, which may be hereditary and/or acquired, are also risk factors. Acquired risk factors include malignancy, hospitalization, surgery, venous trauma, immobilization, estrogen therapy, pregnancy, and the antiphospholipid antibodies. Risk factors for a first episode of VTE are generally also risk factors for recurrence, although the associated relative risk for thrombosis may differ for a first and subsequent event.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 15199510     DOI: 10.1055/s-2001-14668

Source DB:  PubMed          Journal:  Semin Vasc Med        ISSN: 1528-9648


  23 in total

1.  High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism.

Authors:  Matteo Nicola Dario Di Minno; Antonella Tufano; Anna Rusolillo; Giovanni Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Optimized image reconstruction for detection of deep venous thrombosis at multidetector-row CT venography.

Authors:  Marco Das; Georg Mühlenbruch; Andreas Horst Mahnken; Claudia Weiss; U Joseph Schoepf; Christianne Leidecker; Rolf W Günther; Joachim Ernst Wildberger
Journal:  Eur Radiol       Date:  2005-08-02       Impact factor: 5.315

3.  Absence of IFN-γ accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in mice.

Authors:  Mizuho Nosaka; Yuko Ishida; Akihiko Kimura; Yumi Kuninaka; Masanori Inui; Naofumi Mukaida; Toshikazu Kondo
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

4.  Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database.

Authors:  Ameet Sarpatwari; Dimitri Bennett; John W Logie; Amit Shukla; Kathleen J Beach; Adrian C Newland; Simon Sanderson; Drew Provan
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

Review 5.  Diagnosis of pulmonary embolism.

Authors:  Clive Kearon
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

Review 6.  [Venous interventions--part 1: techniques and lower torso thromboses].

Authors:  L Kamper; K Krüger; A Altenburg; M Mansour; P Reimer; P Haage
Journal:  Radiologe       Date:  2009-03       Impact factor: 0.635

7.  Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity.

Authors:  R Rolla; M Vidali; R Serino; P Pergolini; E Albano; G Bellomo
Journal:  Clin Exp Immunol       Date:  2007-05-04       Impact factor: 4.330

8.  The treatment of deep vein thrombosis in the pelvis and leg.

Authors:  Viola Hach-Wunderle; Markus Düx; Max Zegelman; Anja Hoffmann; Florian Präve; Wolfgang Hach
Journal:  Dtsch Arztebl Int       Date:  2008-01-07       Impact factor: 5.594

Review 9.  The role of ethnicity, age and gender in venous thromboembolism.

Authors:  Martina Montagnana; Emmanuel J Favaloro; Massimo Franchini; Gian Cesare Guidi; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

10.  Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?

Authors:  R Kreidy; N Irani-Hakime
Journal:  Vasc Health Risk Manag       Date:  2009-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.